Logo image
Mae III positively detects the mitochondrial mutation associated with type I Leber's hereditary optic neuropathy
Journal article   Peer reviewed

Mae III positively detects the mitochondrial mutation associated with type I Leber's hereditary optic neuropathy

Edwin M Stone, Jeffrey M Coppinger, Randy H Kardon and John Donelson
Archives of ophthalmology (1960), Vol.108(10), pp.1417-1420
10/1990
DOI: 10.1001/archopht.1990.01070120065030
PMID: 1977373

View Online

Abstract

Leber's hereditary optic neuropathy is a blinding disease that usually causes acute or subacute central visual loss in adolescent and young adult males. In patients who lack a family history of a similar illness, Leber's disease has been a diagnosis of exclusion. The recent discovery of a specific mitochondrial mutation in many pedigrees affected with the disease has provided the basis for rapid molecular diagnosis of one genetic type of Leber's disease. We have developed a new method, based on a Mae III (Boehringer Mannheim Biochemicals, Indianapolis, Ind) restriction fragment length polymorphism, for detecting the Wallace-type Leber's mutation. The method has several advantages over the previously used SfaN I method that make it more suitable for use as a general laboratory test. We demonstrate the utility of this new test in the diagnosis of Leber's disease in a patient with no family history of visual loss.
Polymerase Chain Reaction Mutation Optic Atrophies, Hereditary - genetics Electrophoresis, Polyacrylamide Gel Humans Molecular Sequence Data Male Visual Acuity DNA, Mitochondrial - genetics Polymorphism, Restriction Fragment Length Pedigree Base Sequence Adult Optic Atrophies, Hereditary - diagnosis Deoxyribonucleases, Type II Site-Specific

Details

Metrics

Logo image